UniProtKB/Swiss-Prot P21583: Variant p.Leu104Val

Kit ligand
Gene: KITLG
Feedback?

Variant information Variant position:

104 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Leucine (L) to Valine (V) at position 104 (L104V, p.Leu104Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In WS2F; uncertain significance; reduces secretion. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs864309655 [ dbSNP | Ensembl ]

Sequence information Variant position:

104 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

273 The length of the canonical sequence.
Location on the sequence:

LLDKFSNISEGLSNYSIIDK L VNIVDDLVECVKENSSKDLK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LLDKFSNISE---GLSNYSIIDKLVNIVDDLVECVKENSSKD-LK

                              LLDKFSNISE---GLSNYSIIDKLVKIVDDLVECTEGYSFE

Mouse                         LLDKFSNISE---GLSNYSIIDKLGKIVDDLVLCMEENAPK

Rat                           LLDKFSNISE---GLSNYSIIDKLGKIVDDLVACMEENAPK

Pig                           LLDKFSNISE---GLSNYSIIDKLVKIVDDLVECMEEHSFE

Bovine                        LLDKFSNISE---GLSNYCIIDKLVKIVDDLVECMEEHSSE

Goat                          LLDKFSNISE---GLSNYSIIDKLVKIVDDLVECMEEHSFE

Cat                           LLDKFSNISE---GLSNYSIIDKLVKIVDDLVECVEGHSSE

Horse                         LLEKFSNISE---GLSNYSIIDKLVKIVDDLVECMEEHSSE

Chicken                       LLQKFSDISDMSDVLSNYSIINNLTRIINDLMACLAFDKNK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	26 – 273	Kit ligand
Chain	26 – 190	Soluble KIT ligand
Topological domain	26 – 214	Extracellular
Site	97 – 97	Not glycosylated
Glycosylation	90 – 90	N-linked (GlcNAc...) asparagine; partial
Glycosylation	118 – 118	N-linked (GlcNAc...) asparagine; partial
Disulfide bond	29 – 114
Disulfide bond	68 – 163
Helix	97 – 114

Literature citations
Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2.
Zazo Seco C.; Serrao de Castro L.; van Nierop J.W.; Morin M.; Jhangiani S.; Verver E.J.; Schraders M.; Maiwald N.; Wesdorp M.; Venselaar H.; Spruijt L.; Oostrik J.; Schoots J.; van Reeuwijk J.; Lelieveld S.H.; Huygen P.L.; Insenser M.; Admiraal R.J.; Pennings R.J.; Hoefsloot L.H.; Arias-Vasquez A.; de Ligt J.; Yntema H.G.; Jansen J.H.; Muzny D.M.; Huls G.; van Rossum M.M.; Lupski J.R.; Moreno-Pelayo M.A.; Kunst H.P.; Kremer H.;
Am. J. Hum. Genet. 97:647-660(2015)
Cited for: VARIANT DCUA 67-HIS-CYS-68 DELINS ARG; CHARACTERIZATION OF VARIANT DCUA 67-HIS-CYS-68 DELINS ARG; INVOLVEMENT IN DCUA; VARIANT WS2F VAL-104; CHARACTERIZATION OF VARIANT VAL-104; SUBCELLULAR LOCATION (ISOFORM 2);

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.